| ||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||
|
| ||||||||||||||||||||||||
ADHD is defined as symptoms of hyperactivity, impulsivity, and inattention
beyond what's usual for a developmental age. A 6-year-old is expected to be
more hyperactive than a 10-year-old. But a 6-year-old with ADHD can be
much more hyperactive than a 6-year-old without ADHD in certain settings;
likewise inattention; likewise impulsivity. Those are observed in the home, in
school, in play situations. But we don't have a test. We don't have an
objective way of definitively saying, "This person has ADHD, or does not," in
part, because we don't really understand what it is. ...
We don't yet know what's going on in ADHD. We've approached it in a number of
different ways, and one way has been to look at what brain regions are smaller,
or different. What we've found is that there are a few regions that are
smaller in kids who have ADHD. There are other groups that are looking at
functional MRI, or at SPECTA (Single Photon Emission Computomography), usually
in adults who have ADHD. And most of the evidence converges and suggests that
regions that are rich in dopamine are involved. And that's interesting,
because dopamine is one of the chemicals that Ritalin boosts.
... Dopamine is an important signal that certain parts of the brain use to regulate movement. If you don't have dopamine in those brain regions, you develop Parkinson's disease. But it's also apparently used to send a signal that something important is happening. ... It used to be said that dopamine was the reward chemical--that if something was rewarding, then you would release dopamine. It turns out to be more complicated than that. It's not just whether something's going to feel good, or be rewarded; it's more if there's a possibility that something would feel good. If an animal knows that they're going to be rewarded when they correctly do a task, then dopamine is no longer involved. But when the animal thinks that maybe this is the way to solve the task, dopamine is leading the way, saying, "This, try this, try this." So it's a very important signaling molecule. And it's classified officially, I guess, or technically, as a neurotransmitter. But it's probably more appropriately described as a neuro-modulator, which means that it sets or modulates the tone for these complex systems.
So we think that it's important to have optimal levels of dopamine in various
brain regions; if they're not optimal, then things don't work as well. So
that's a very sort of cut-and-dried, simplistic possible explanation of what's
going on in dopamine and ADHD.
The leading theory is probably that, effectively, your brain doesn't save its dopamine and use it as well as it might. Now, that's not been conclusively shown. There are two studies in adults with ADHD that suggest that that's true in the basal ganglia. And because they use radiation, it's going to be very difficult to repeat those studies in children. But it is sort of exciting to have that new information. In fact, in one of the studies, they took individuals who had never been treated for their ADHD, tested them, and then gave them Ritalin and re-tested them--and found that the Ritalin, in fact, did affect the molecule that they were trying to have an effect on. And the result of that should be an increase in dopamine in the basal ganglia--we know in the basal ganglia, because we can measure it. We don't know what's going on in the frontal lobes; we don't know what's going on in the cerebellum, because there's much less dopamine there, and so it's much more difficult to measure.
So it's only a partial answer. If you're an adult with ADHD, I can make some
tentative conclusions. But if you're a child with ADHD, I don't yet know
what's going on in your brain.
No. There are some studies that can't be done in children, because the
regulations that we work under require that we limit the level of risk to
negligible levels, especially if we're going to be studying healthy children
as control subjects. So we have to think of other ways to get indirect
information.
The manifestations of ADHD change with age. And so I think some individuals
can be said to outgrow their ADHD. It used to be believed that all kids with
ADHD would outgrow it. And now we also know that that's not true. For some
people, they continued to have difficulties, whether it's in high school, or
college, or at work, or with relationships. But it's not everyone. A
significant proportion get better . We don't know what the proportion is,
because we'd need a very large study, and we'd need to follow people over a
long period of time. ...
Well, there are limitations because we've only just started. Until about 10 years ago, we couldn't really quantify or measure anything in the brain, especially in children. And so we had to rely on impressions. If you go back and look at the journals that were written in the 1960s, 1970s, 1980s, some of them were almost like novels. They're very rich with detail and texture, but have very few numbers. And until you could start counting things, or measuring them, it's hard to really make progress. Once we had magnetic resonance imaging and other sorts of techniques like that, we're able to start measuring and studying the brain.
... When I get discouraged, I think about a map that I have in my house that
came from an exhibit in the Smithsonian from 1500. It's a map of the New
World, and you can tell that they knew about Florida--there's a peninsula.
They have an idea about the East Coast, and even Texas, but you wouldn't want
to use that to drive from Tallahassee to Atlanta, because it's just too crude.
So we're about at that level of getting an idea of where the major pieces are,
and what their relationships may be. And it's better than it used to be. But
we've only been at it for about 10 or 12 years. ...
The posterior inferior vermis of the cerebellum is smaller in ADHD. I think
that that is a true fact. It's taken about five years to convince myself that
that's the case. That's about as much as I know--that I'm confident
about.
I don't know what it means, but it's true, and it's a fact. And that's the
next step.
... Even though it's only about 10 percent of the size of the total brain, there are more neurons in the cerebellum than in the entire rest of the brain combined, which is fascinating. But the cerebellum has never been thought to be that important, because you can remove it, and nothing terrible happens. But recently, people have noticed that the cerebellum is very involved.
One person says that the cerebellum is a little bit like a co-processor--it's
useful, but it's not necessary. And he believes that its function is really to
help the other parts of the brain work better. That makes some sense to me,
that maybe that's what's not working so well in ADHD. People with ADHD can do
anything; they just don't do it quite so well. It's a disorder of efficiency,
or inefficiency, as much as anything, I believe. I'm excited about the
possibility that this is an important clue to understanding this. But how to
build on that is something that I'm still struggling with. ...
Well, I'm trying to answer probably too many different questions. One question is whether this difference in the cerebella vermis is the most important difference, and if that somehow has effects in other brain regions, and therefore produces a kind of downstream effect of ADHD.
I'm also involved in collecting samples for genetic analysis, to see if we can
find what genes increase the risk that someone's going to have ADHD. We know
that it's not likely to be a simple association between a gene and the
disorder. But likely, almost certainly, genes do influence how hyperactive,
how impulsive, how inattentive someone is. And that's a long-term kind of
project. I'd like to think of some newer ways of imaging the brain in
children, to see if we can see the functioning of the brain. But those are
perhaps a year or two away.
I don't know. I don't think we'll know until we've found it. ... We'd like
to find a biological marker. We'd like to find some sort of objective way,
something that gives us a real sense that we understand what's going on in
ADHD. The problem is, we're searching in the dark, and don't know where that
clue is going to be. My personal opinion is that we'll trip over it in the
next three to five years. ...
... A very respected researcher wrote an article that was entitled, "How is Ritalin, or Methylphenidate, Like Cocaine?" The researcher wrote a paper in which she examined the similarities between Methylphenidate, or Ritalin, and cocaine. They go to some of the same places in the brain; but there are also some major differences. Cocaine leaves the basal ganglia much more rapidly. She also studied the differences between injecting Ritalin and swallowing Ritalin, and it makes a huge difference in the kind of response you get. So, Ritalin, when it's taken as a pill, has a very safe profile. When it's injected or when it's snorted, it becomes a very dangerous drug. So I think that that's the truth in this. And it's not something to play with. There have been deaths from kids who thought it was fun to take Ritalin recreationally. But when it's taken as prescribed, it's remarkably safe. There's always a risk. But there are fewer adverse events than from vitamins with iron, which are quite toxic when children take too many of them, or aspirin, or Tylenol, or antibiotics. We're prescribing this powerful substance to kids, and yet we don't quite know what's happening. There are two parts to that. When you work with these children and their families, there's a real level of distress and unhappiness that makes us want to do something to help. Over 60 years ago, a man named Charles Bradley found out by accident that medicines like Ritalin or Dexedrine have profound effects on the behavior of children or adults that have these kinds of problems. It was completely by accident. He was hoping that this would help their headaches. It didn't help the headaches, but the teachers were just amazed at how these children--who were locked up because they were not safe to be outside an institution--were all of a sudden able to sit in class and learn math. And so, part of the explanation is that there are some very unhappy children and parents. And for many of them, these medications reduce that unhappiness--not for all--but for many.
The other part of the question--our level of ignorance--is true. But we're
pretty ignorant about almost everything. And if we only used treatments that
we understand comprehensively, we wouldn't do very much, and people would be
the worse off. The attempt is to learn from our ignorance, by systematic
trials, by advancing what we know. And we have advanced--appreciably--which
isn't to say that we know enough. But we know quite a bit. The opinion of the
vast majority of physicians in this country, and in several other countries .
. . is that the balance of benefit and risk is positive enough for most cases
to make this worth trying.
We don't know long-term consequences of many things. And sometimes, the long-term consequences of not doing something have to be weighed as well. The best way to learn the long-term consequences of a treatment ... is to do an impossible study--to take 1,000 children and randomly decide who's going to get Ritalin and who's going to get placebo for the next 20 years, and not let their parents change their minds about what they're going to do. That's not going to be done. ... We also know, from the fact that millions of children have taken these medicines, that the risks are not dramatic or obvious, because those are things that people notice. We can't be glib or certain that there are no long-term risks. But there's no large mass of doubts amassing and suggesting that we have a generation of children developing cancer or things of that type.
But it is an open question. And when the decision is made whether or
not to use medications in the child, the uncertainty about that needs to be
acknowledged. For some people, that weighs more than the potential benefit;
and for other people, the distress is more important. But that's a personal
decision that, I think, in most cases, parents have to make with
recommendations and advice from a physician. I don't think that that's an
easy call, but uncertainty is a constant against all medicine. ...
We use the MRI scanner to measure the brain, and to measure regions of the
brain. We're very interested in the basal ganglia, the cerebellum, because
those are regions that we think are important, and also, they're measurable.
We've been doing this for almost 10 years. We've had hundreds of kids who've
come through two, three, four times. And one of our goals is to develop growth
curves for the brain, like pediatricians have had for height and weight, so
that we can see what's the expected pattern of growth.
Several years ago, we started a study of ADHD in girls, because it's always
been thought to be almost exclusively in boys. It turns out that a lot of
girls have it and no one ever notices. ...
It depends how you compare it. Some girls can be very hyperactive. But
depending on the age, some girls will be much more hyperactive than girls who
don't have ADHD, but they're usually less hyperactive than hyperactive boys of
the same age. The problems with concentrating on schoolwork, which we normally
describe as inattention, can certainly be present to the same degree. ...
It's never as big as you want it to be. ... We've scanned 187 individual children who have ADHD over the last 10 years. Many of those children have had more than one scan, so we have over 300 to 400 scans. We're talking about both boys and girls of different ages.
... The brain of a 6-year-old is not exactly like the brain of a
12-year-old, or an 18-year-old. We'd like to have a few more. ...
Well, our first question was, if ADHD is related to the brain, what parts of
the brain are different? We have some initial answers to that. The next
question is, what happens to those brain regions as kids get older? And our
preliminary answers seem to be that they develop fairly normally, at the same
rate as they do in our control kids. But if they were smaller to begin with,
they stay somewhat smaller. We're still doing measurements in some brain
regions. So we may find other things, but we don't have any other results
yet.
We compare 50 or 60 kids who are healthy to 50 or 60 kids who have ADHD. We
see that the posterior inferior vermis, which is the small part of the
cerebellum, is smaller by about 12 percent in the kids who have ADHD. We also
find that the caudate is about 6 percent smaller. Other findings are more
tenuous, but those are our two main findings.
... A number of years ago, we knew that we needed to check to see whether or not the changes that we observed, or the differences we have observed, were because of ADHD, or because the kids were taking medicines like Ritalin, or Dexedrine, or Adderall.
We can't do a study that puts kids on medicine, and puts other kids on placebo,
and then follows them. Instead, we've been recruiting children who were never
medicated, and then we follow them over time. We compare them to kids who have
been on medicine. Within the next year, we think we'll have that completed.
Our preliminary findings are that it's not related to the medication. But
we're not finished getting the scans or measuring them.
We know the first step of how medicines like the stimulants work, but we don't
know many other things. We know that they increase dopamine and
norepinephrine, which are important neurochemicals, in regions where those
chemicals are being released normally. We know that they enhance the amount
that's available to those neurons. But we don't know if that is important in
all of the brain regions that have those chemicals, or if they're interacting
in more complicated ways. We just flat-out don't know.
... The first person who found out that stimulants can be helpful for
hyperactive children was Charles Bradley. And he guessed, or hypothesized,
that they must be stimulating some of the centers that allow inhibition and
self-control more than they stimulate other parts of the brain. That was in
1937, and that's still a pretty good explanation of what we know. So we
haven't progressed as much as we'd like. We know that they do work in many
kids.
Yes. But I'm also glad that I know more than I used to. It's both half full
and half empty. It's not even half full. It's about a tenth full. ...
It reaches into some core issues. The idea that not all children are born
perfect is a very hard one to deal with. The question about the long-term
risks, I think, is an important one. And then there are historical reasons for
people to be worried about what psychiatrists would propose in some cases. . .
.
If I had a child that had ADHD, with what I know, I'd be willing to have that
child take medication, but I'd want to make sure that it was really necessary.
And I would put it off as long as I could; I would not be comfortable
medicating a child who was two, three, four years of age, unless it was the
only option. ...
I think it's important to look at the real issues. One of the real issues is
that this can be a complicated process to sort out. And if physicians or
clinicians don't have the time ... if someone's not willing to pay for that
and to say, "This is an important thing," then there are going to be cases
where kids fall through the cracks, or instant diagnoses are made that may be
incomplete, or incorrect. ...
readings · adhd in schools · interviews · discussion · the producers · viewers' guide synopsis · tapes & transcripts · press reaction · credits frontline · wgbh · pbs online
pill photograph copyright ©2001 photodisc all rights reserved | ||||||||||||||||||||||||